JMP Securities maintained its optimistic stance on AtriCure Inc. (NASDAQ:ATRC), reiterating a Market Outperform rating and a $60.00 price target. The firm's analysts highlighted their anticipation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback